Vmn2r48 Inhibitors
Vmn2r48 operate through a range of distinct mechanisms to modulate the functional activity of this protein. Bicuculline, a specific antagonist of GABAA receptors, can inhibit neural circuits involving GABAA, thereby reducing the excitatory or inhibitory tone within the networks that Vmn2r48 is a part of. This reduction in GABAergic activity can alter the overall neural responsiveness, including that of neurons expressing Vmn2r48. Similarly, CNQX, an AMPA receptor antagonist, suppresses excitatory neurotransmission, which can decrease the excitatory drive in circuits where Vmn2r48 is active. This results in a reduced neural activity in those circuits, indirectly affecting the functional output of Vmn2r48-expressing neurons. Furthermore, haloperidol acts as a dopamine D2 receptor antagonist, and by blocking these receptors, can diminish the dopaminergic modulation of neurons involved in Vmn2r48 pathways. Ketanserin, which targets serotonin 2A receptors, can dampen the pathways that involve Vmn2r48 by antagonizing serotonergic transmission, thus affecting the protein's functionality.
Vmn2r48 is further modulated by inhibitors that target ion channels and neurotransmitter systems. Tetrodotoxin, for instance, blocks voltage-gated sodium channels, preventing action potential propagation in neurons, including those expressing Vmn2r48, leading to decreased neuronal activity. D-AP5, which is an NMDA receptor antagonist, and LY341495, a metabotropic glutamate receptor antagonist, both inhibit glutamate receptors that are pivotal for excitatory neurotransmission and synaptic plasticity. By inhibiting these receptors, the compounds can suppress excitatory input and modulate neurotransmission in Vmn2r48-expressing circuits. Nimodipine, which inhibits L-type calcium channels, can decrease calcium influx, thus reducing neurotransmitter release and neuronal excitability in neurons where Vmn2r48 is present. Ondansetron, a 5-HT3 receptor inhibitor, and scopolamine, a muscarinic acetylcholine receptor antagonist, can alter neurotransmission by blocking their respective receptor types, which in turn can modulate the activity of Vmn2r48. Lastly, yohimbine, an alpha-2 adrenergic receptor antagonist, can reduce adrenergic tone in sensory pathways, which might be involved in the modulation of Vmn2r48 function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Bicuculline is a specific antagonist of GABAA receptors. Vmn2r48 is a G protein-coupled receptor (GPCR), and while it does not interact with GABAA directly, the inhibition of GABAA receptors can alter neural activity and potentially reduce the neural responses mediated by Vmn2r48 activation. | ||||||
6-Cyano-7-nitroquinoxaline-2,3-dione | 115066-14-3 | sc-505104 | 10 mg | $208.00 | 2 | |
CNQX is an AMPA receptor antagonist that can inhibit excitatory neurotransmission. By decreasing excitatory drive, CNQX may reduce the overall neural activity in circuits where Vmn2r48 is active, thereby indirectly inhibiting the functional output of Vmn2r48-expressing neurons. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol is a dopamine D2 receptor antagonist. Since dopaminergic signaling can modulate olfactory and pheromone processing, blocking D2 receptors may diminish the dopaminergic modulation on neurons that express Vmn2r48, indirectly inhibiting its functional role in signal transduction. | ||||||
Ketanserin | 74050-98-9 | sc-279249 | 1 g | $700.00 | ||
Ketanserin is a serotonin 2A receptor antagonist. Serotonergic signaling can influence various sensory pathways, including those in which Vmn2r48 might be involved. By antagonizing 5-HT2A receptors, ketanserin could dampen the pathways that facilitate Vmn2r48 function. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $82.00 $333.00 | 1 | |
Ondansetron is a selective inhibitor of 5-HT3 receptors. If Vmn2r48-expressing neurons are modulated by serotonergic input through 5-HT3 receptors, blocking these receptors could indirectly reduce the functional activity of Vmn2r48 by altering neurotransmission in related pathways. | ||||||
LY 341495 | 201943-63-7 | sc-361244 sc-361244A | 1 mg 10 mg | $89.00 $223.00 | 1 | |
LY341495 is a metabotropic glutamate receptor antagonist. By inhibiting these receptors, LY341495 can modulate synaptic plasticity and neurotransmission in pathways where Vmn2r48 is present, thereby indirectly inhibiting Vmn2r48 function by altering the neural network dynamics. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Nimodipine is a calcium channel blocker that can inhibit L-type calcium channels. By reducing calcium influx, nimodipine can decrease neurotransmitter release and neuronal excitability, potentially reducing the functional activity of neurons expressing Vmn2r48. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone is a glucocorticoid receptor antagonist that can impact stress-related pathways. Since stress can influence various sensory systems, blocking glucocorticoid receptors may indirectly inhibit pathways that Vmn2r48 is part of, thus modulating its functional role. | ||||||
Scopolamine | 51-34-3 | sc-473216 sc-473216A sc-473216B | 100 mg 500 mg 1 g | $172.00 $506.00 $786.00 | 2 | |
Scopolamine is a muscarinic acetylcholine receptor antagonist. By inhibiting muscarinic receptors, scopolamine can affect neural circuits that control sensory processing, potentially impacting the functionality of neurons expressing Vmn2r48 by altering cholinergic transmission. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine is an antagonist of alpha-2 adrenergic receptors. Adrenergic signaling can modulate sensory processing, and by blocking alpha-2 receptors, yohimbine may indirectly inhibit Vmn2r48 function by reducing adrenergic tone in the relevant neural pathways. | ||||||